Form D · Other

Gerosynth Laboratories, Inc.

Bloomington, MN · CIK 0001941474

Offering snapshot reported Dec 12, 2024 · SEC filing

Reported sold
$1.64M
Offering amount: $5M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 2, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 12, 2024Initial$1,638,500No comparison15SEC filing
May 9, 2024Initial$1,379,500No comparison23SEC filing
Oct 18, 2023Amendment$2,680,000$645,000vs Aug 11, 202334SEC filing
Aug 11, 2023Initial$2,035,000No comparison27SEC filing
Mar 13, 2023Initial$255,000No comparison5SEC filing
Feb 28, 2023Amendment$255,000$0vs Aug 30, 20225SEC filing
Aug 30, 2022Initial$255,000No comparison5SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-531876
SAFEs

Source: Form D, filed Dec 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick Chuinard Director, Executive
Pat Chuinard Director
Laurie Chuinard Director
Erin Clark Director, Executive
Brian Hatlevig Director
Amy Hatlevig Director
Alisha O'dell Director, Executive
Bethany Pope Director, Executive
Paige Scherer Director

Issuer details

Industry: Other (See others in industry)

Address:
8500 Normandale Lake Blvd., Suite 350
Bloomington, MN, 55437